New Year Bumper Sale @ Rs. 1 X
Virolans 150 Mg/30 Mg/200 Mg Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Virolans 150 Mg/30 Mg/200 Mg Tablet have also been mentioned below.
The correct dosage of Virolans 150 Mg/30 Mg/200 Mg Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Some other side effects of Virolans 150 Mg/30 Mg/200 Mg Tablet have been listed ahead. These side effects of Virolans 150 Mg/30 Mg/200 Mg Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Virolans 150 Mg/30 Mg/200 Mg Tablet's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Virolans 150 Mg/30 Mg/200 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Virolans 150 Mg/30 Mg/200 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Pancreatitis, Liver Disease must refrain from the use of Virolans 150 Mg/30 Mg/200 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Virolans 150 Mg/30 Mg/200 Mg Tablet are listed in the contraindications section below.
Additionally, Virolans 150 Mg/30 Mg/200 Mg Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Virolans 150 Mg/30 Mg/200 Mg Tablet is not safe while driving, and is not addiction.
Virolans 150 Mg/30 Mg/200 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Virolans 150 Mg/30 Mg/200 Mg Tablet safe for pregnant women?
Virolans may have some side effects during pregnancy. Pregnant women should discontinue the use of Virolans, and talk to their doctor, if they notice any discomfort.
Is the use of Virolans 150 Mg/30 Mg/200 Mg Tablet safe during breastfeeding?
Side effects of Virolans for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Virolans 150 Mg/30 Mg/200 Mg Tablet on the Kidneys?
Virolans may have mild side effects on the kidneys.
What is the effect of Virolans 150 Mg/30 Mg/200 Mg Tablet on the Liver?
Virolans is rarely harmful for the liver.
What is the effect of Virolans 150 Mg/30 Mg/200 Mg Tablet on the Heart?
You can take Virolans without any fear of damage to the heart.
Virolans 150 Mg/30 Mg/200 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Virolans 150 Mg/30 Mg/200 Mg Tablet unless your doctor advises you to do so -
Is this Virolans 150 Mg/30 Mg/200 Mg Tablet habit forming or addictive?
Virolans 150 Mg/30 Mg/200 Mg Tablet is not addictive in nature.
Interaction between Food and Virolans 150 Mg/30 Mg/200 Mg Tablet
Some foods when eaten with Virolans 150 Mg/30 Mg/200 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Virolans 150 Mg/30 Mg/200 Mg Tablet
Taking alcohol with Virolans 150 Mg/30 Mg/200 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viramune® (nevirapine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807